Envista Reports Fourth Quarter 2024 Results
1. Envista's Q4 2024 sales reached $653 million, up 2.0%. Core sales growth indications are positive. 2. Adjusted EBITDA margin remains consistent at 13.9%. Strong free cash flow demonstrates operational efficiency. 3. Net income improved to $1 million from a $217 million loss YoY. This reflects operational recovery. 4. Outlook for 2025 suggests core sales growth of 1%-3%. Adjusted EPS guidance provides market confidence. 5. Growth in implant sales and aligners indicates competitive positioning in market segments.